Eagle Pharmaceuticals Inc (NAS:EGRX)
$ 3.54 -0.27 (-7.09%) Market Cap: 45.87 Mil Enterprise Value: 105.50 Mil PE Ratio: 3.89 PB Ratio: 0.18 GF Score: 62/100

Eagle Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 23, 2020 / 02:00PM GMT
Release Date Price: $48.58 (+1.17%)
Michael Graves
Eagle Pharmaceuticals, Inc. - Independent Chairman

Good morning. I am Michael Graves, Chairman of the Board of Directors of Eagle Pharmaceuticals. It is my great pleasure to welcome you to the company's 2020 Annual Meeting of Stockholders.

This meeting was called to be held at 10:00 a.m. today. And it now being 10:00 a.m., I will call this meeting to order.

It is my pleasure to introduce Pete Meyers, Chief Financial Officer of Eagle Pharmaceuticals, who will proceed with the additional instructions.

Pete A. Meyers
Eagle Pharmaceuticals, Inc. - CFO

Good morning. I'm Pete Meyers, Chief Financial Officer of Eagle Pharmaceuticals, Inc. It is great to be here with you virtually at our Annual Meeting of Stockholders.

I would like to start off by introducing the senior management team members of the company present virtually today. Scott Tarriff, CEO and Director; David Pernock, President and Chief Operating Officer; Adrian Hepner, Chief Medical Officer; Dan O'Connor, Chief Strategy Officer and Head of Corporate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot